Researchers say the Trump administration's plan to slash payments for indirect costs will hamper new medical science. One example? A lab studying respiratory viruses faces losing half its staff.

The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.

Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.

As the dust settles from the first wave of firings at health agencies, here's how many people got cut and the impact of the roles that were lost.

Georgia’s statewide public health conference has been canceled, and researchers are navigating disruptions in federal data accessibility and funding.

What do National Institutes of Health funding cuts mean for universities? We ask Holden Thorp, editor-in-chief of the journal Science and former University of North Carolina at Chapel Hill chancellor.

There's widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and at institutions dependent on the agency's funding.

Research and basic information on subjects ranging from tuberculosis surveillance to adolescent health disappeared from federal health agency websites.

An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded. Scientists worry about disruptions to critical research.

Dr. Jay Bhattacharya, a Stanford health researcher, is in line to lead the National Institutes of Health. Early in the pandemic he argued against lockdowns and focusing on people at highest risk.

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.

The National Institutes of Health, the crown jewel of biomedical research in the U.S., could face big changes under the new Trump administration, some fueled by pandemic-era criticisms of the agency.

During the early days of the pandemic, former NIH Director Dr. Francis Collins became a familiar voice steering the country through an unprecedented public health crisis.

Now, he is going through his own health crisis, an aggressive form of prostate cancer. By talking about it publicly he hopes to draw attention to routine screening.

For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.

Email us at considerthis@npr.org.

The mysterious ailments that became known as Havana syndrome left no physical evidence of injury or disease, according to two government studies.

The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.